Order Article Reprints

Biernat MM, Kolasińska A, Kwiatkowski J, Urbaniak-Kujda D, Biernat P, Janocha-Litwin J, Szymczyk-Nużka M, Bursy D, Kalicińska E, Simon K, et al. Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19. Viruses. 2021; 13(3):436. https://doi.org/10.3390/v13030436

Biernat, Monika Maria, Anna Kolasińska, Jacek Kwiatkowski, Donata Urbaniak-Kujda, Paweł Biernat, Justyna Janocha-Litwin, Małgorzata Szymczyk-Nużka, Dawid Bursy, Elżbieta Kalicińska, Krzysztof Simon, and et al. 2021. "Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19" Viruses 13, no. 3: 436. https://doi.org/10.3390/v13030436

Biernat, M. M., Kolasińska, A., Kwiatkowski, J., Urbaniak-Kujda, D., Biernat, P., Janocha-Litwin, J., Szymczyk-Nużka, M., Bursy, D., Kalicińska, E., Simon, K., Mazur, G., & Wróbel, T. (2021). Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19. Viruses, 13(3), 436. https://doi.org/10.3390/v13030436